Abstract
Background: Coumarin and chalcone are important secondary plant metabolites that exhibit a range of biological activities. Accordingly, the synthetic derivatives and analogs of these molecules have attracted attention as potential pharmacological agents.
Objective: This study aims to study new antidepressants with high biological activity and low side effects, and to provide a basis for the treatment of epilepsy and depression.
Methods: In this study, a series of chalcone derivatives containing a coumarin moiety (2a-2s) were designed, synthesized, and evaluated using classic antidepressant and anticonvulsant mouse models.
Results: Forced swimming test results revealed that all but one of the compounds tested significantly decreased immobility time at a dose of 10 mg/kg and exhibited some antidepressant activities. Furthermore, compounds 2a, 2c, 2h, and 2k exhibited relatively high antidepressant effects in a dosedependent manner from 10 to 30 mg/kg. Maximal electroshock seizure tests showed that compounds 2a, 2b, 2c, 2h, 2l, 2r, and 2s exhibited anticonvulsant activities at a dose of 30 mg/kg.
Conclusion: Accordingly, compounds 2a, 2c, and 2h showed promise as antidepressant adjunct therapy agents for treating depression in patients with epilepsy. Chromatographic neurochemical analysis of the mouse brain tissue revealed that the antidepressant effects of the compounds may be mediated by an increase in serotonin level.
Keywords: Chalcones, chromen, coumarin, anti-depressant, anticonvulsant, neurotransmitters.
Letters in Drug Design & Discovery
Title:Synthesis of Chromen-1-phenylpropan-1-one Derivatives and their Antidepressant/ Anticonvulsant Activities
Volume: 18 Issue: 12
Author(s): Shan-Shan Zhang, Wei-Hua Liu, Zhi-Wen He, Qiu-Wan Tan and Li-Ping Guan*
Affiliation:
- Food and Pharmacy College, Zhejiang Ocean University, Zhejiang, Zhoushan 316022,China
Keywords: Chalcones, chromen, coumarin, anti-depressant, anticonvulsant, neurotransmitters.
Abstract:
Background: Coumarin and chalcone are important secondary plant metabolites that exhibit a range of biological activities. Accordingly, the synthetic derivatives and analogs of these molecules have attracted attention as potential pharmacological agents.
Objective: This study aims to study new antidepressants with high biological activity and low side effects, and to provide a basis for the treatment of epilepsy and depression.
Methods: In this study, a series of chalcone derivatives containing a coumarin moiety (2a-2s) were designed, synthesized, and evaluated using classic antidepressant and anticonvulsant mouse models.
Results: Forced swimming test results revealed that all but one of the compounds tested significantly decreased immobility time at a dose of 10 mg/kg and exhibited some antidepressant activities. Furthermore, compounds 2a, 2c, 2h, and 2k exhibited relatively high antidepressant effects in a dosedependent manner from 10 to 30 mg/kg. Maximal electroshock seizure tests showed that compounds 2a, 2b, 2c, 2h, 2l, 2r, and 2s exhibited anticonvulsant activities at a dose of 30 mg/kg.
Conclusion: Accordingly, compounds 2a, 2c, and 2h showed promise as antidepressant adjunct therapy agents for treating depression in patients with epilepsy. Chromatographic neurochemical analysis of the mouse brain tissue revealed that the antidepressant effects of the compounds may be mediated by an increase in serotonin level.
Export Options
About this article
Cite this article as:
Zhang Shan-Shan , Liu Wei-Hua , He Zhi-Wen , Tan Qiu-Wan and Guan Li-Ping *, Synthesis of Chromen-1-phenylpropan-1-one Derivatives and their Antidepressant/ Anticonvulsant Activities, Letters in Drug Design & Discovery 2021; 18 (12) . https://dx.doi.org/10.2174/1570180818666210804143223
DOI https://dx.doi.org/10.2174/1570180818666210804143223 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Call for Papers in Thematic Issues
Navigating the Frontier: Probiotics' Promising Path in Combatting Viral Respiratory Infections, Spotlight on Coronaviridae.
Probiotics, well-known for their role in gut health, show promise in preventing and managing respiratory virus infections, particularly in children and at-risk populations. However, the profound influence of novel pathogenic viral RTIs such as coronaviruses has reshaped perspectives on the potential of probiotics. Despite their potential, significant gaps remain in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype
CNS & Neurological Disorders - Drug Targets Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs
CNS & Neurological Disorders - Drug Targets Casein Kinase 2 Affects Epilepsy by Regulating Ion Channels: A Potential Mechanism
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Nitric Oxide: Implications for the Etiology & Treatment of Central Nervous System Disorders (Guest Editor: Giuseppe Di Giovanni)]
CNS & Neurological Disorders - Drug Targets A Focus on Glucose-Mediated Drug Delivery to the Central Nervous System
Mini-Reviews in Medicinal Chemistry Rationale Design, Synthesis, and Pharmacological Evaluation of Isatin Analogues as Antiseizure Agents
Letters in Drug Design & Discovery Advances in Metal-organic Frameworks (MOFs) based Biosensors for Diagnosis: An Update
Current Topics in Medicinal Chemistry Drug Repositioning: A Monetary Stratagem to Discover a New Application of Drugs
Current Drug Discovery Technologies The Importance of Bioactivation in Computer-Guided Drug Repositioning. Why the Parent Drug is Not Always Enough
Current Topics in Medicinal Chemistry Neurodevelopmental and Neuropsychiatric Perspectives on Respiratory Control: Understanding Congenital and Developmental Disorders
Current Respiratory Medicine Reviews Subject Index to Volume 9
Current Pharmaceutical Design Anticonvulsants – Antidepressants Pharmacokinetic Drug Interactions: The Role of the CYP450 System in Psychopharmacology
Current Drug Metabolism LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase
Current Signal Transduction Therapy The Enigmatic Drug Binding Site for Sodium Channel Inhibitors
Current Molecular Pharmacology Update Clinical Application of Diffusion Tensor Imaging
Current Medical Imaging Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued) Recent Trends in the Discovery of Small Molecule Blockers of Sodium Channels
Current Medicinal Chemistry Maternal Exposure to Quetiapine: Effects on Structural Changes in Developing Brain and its Lasting Impact on Neurobehavioral Impairments in Rat Offspring
Current Psychopharmacology Voxel-Based Morphometry of the Human Brain: Methods and Applications
Current Medical Imaging Expressed Emotion and Eating Disorders: An Updated Review
Current Psychiatry Reviews